Impulse Biomedical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Investors
  • 6

Impulse Biomedical General Information

Description

Developer of medical devices designed to offer assistance in the emergency treatment of anaphylaxis. The company provides proprietary adrenaline auto-injectors that can be customized for any patient, such as the needle length and dose, and primarily serves sectors that require medical devices for asthma and allergy treatments, enabling clinicians to avail of effective technologies to help save lives and reduce the impact of illnesses and chronic diseases on daily life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 160 Sir Lowry Road
  • Unit 403, The Armoury Building, Woodstock
  • Cape Town, Western Cape 7925
  • South Africa
+27 021
Primary Industry
Other Devices and Supplies
Other Industries
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 160 Sir Lowry Road
  • Unit 403, The Armoury Building, Woodstock
  • Cape Town, Western Cape 7925
  • South Africa
+27 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Impulse Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) Upcoming Generating Revenue
5. Later Stage VC 16-May-2025 Completed Generating Revenue
4. Seed Round 01-Feb-2022 Completed Generating Revenue
3. Seed Round 29-Mar-2021 Completed Startup
2. Accelerator/Incubator 02-Feb-2018 $16.4K $16.4K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Impulse Biomedical’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Impulse Biomedical Patents

Impulse Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1121143-S1 Autoinjector Active 13-Dec-2023

Impulse Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Impulse Biomedical Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Launch Africa Ventures Venture Capital Minority
E Squared Venture Capital Minority
Futuregrowth Asset Management Impact Investing Minority
University Technology Fund Venture Capital Minority
Anza Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Impulse Biomedical FAQs

  • When was Impulse Biomedical founded?

    Impulse Biomedical was founded in 2018.

  • Where is Impulse Biomedical headquartered?

    Impulse Biomedical is headquartered in Cape Town, South Africa.

  • What is the size of Impulse Biomedical?

    Impulse Biomedical has 18 total employees.

  • What industry is Impulse Biomedical in?

    Impulse Biomedical’s primary industry is Other Devices and Supplies.

  • Is Impulse Biomedical a private or public company?

    Impulse Biomedical is a Private company.

  • What is Impulse Biomedical’s current revenue?

    The current revenue for Impulse Biomedical is .

  • How much funding has Impulse Biomedical raised over time?

    Impulse Biomedical has raised $166K.

  • Who are Impulse Biomedical’s investors?

    Launch Africa Ventures, E Squared, Futuregrowth Asset Management, University Technology Fund, and Anza Capital are 5 of 6 investors who have invested in Impulse Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process